Stocks
GlaxoSmithKline (GSK) FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF, £ | ? | 5 298 000 000 | 6 752 618 950 | 6 257 522 970 | 3 572 000 000 | 5 824 498 768 | 6 236 295 705 | ||
| Changes by years, y/y, % | -18% | +27% | -7% | -43% | +63% | -2.2% | |||
GlaxoSmithKline. FCF, £
GlaxoSmithKline. FCF, changes, %
GlaxoSmithKline. FCF, sum by quarters, £
GlaxoSmithKline (GSK) FCF US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF, £ | ? | 1 463 000 000 | 2 599 208 130 | 1 476 087 575 | 1 476 087 575 | 698 000 000 | 6 236 295 705 | |
| Changes by years, y/y, % | +118% | +98% | +24% | +24% | +0% | |||
| Changes by quarters, q/q, % | +110% | +78% | -43% | 0% | -53% | |||
